Denosumab and Male Infertility: a Randomized Controlled Double-blinded Intervention Study
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Male infertility
- Focus Therapeutic Use
- 26 Sep 2019 Planned End Date changed from 1 Jan 2021 to 1 Jun 2020.
- 26 Sep 2019 Planned primary completion date changed from 1 Jan 2021 to 1 Jun 2020.
- 25 Mar 2019 Status changed from recruiting to active, no longer recruiting.